These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24192949)

  • 1. Editorial: PPIs and recurrent C. difficile infection: no association?
    Leontiadis GI
    Am J Gastroenterol; 2013 Nov; 108(11):1802-3. PubMed ID: 24192949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Abdallah J; Hassan T; Kyprianou A
    Am J Gastroenterol; 2014 Apr; 109(4):601-2. PubMed ID: 24698870
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggression of C-difficile infections in PPI consumers.
    Daniell HW
    Am J Gastroenterol; 2014 Jun; 109(6):922. PubMed ID: 24896760
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS
    J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
    Arriola V; Tischendorf J; Musuuza J; Barker A; Rozelle JW; Safdar N
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1408-1417. PubMed ID: 27677811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Daniell.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2014 Jun; 109(6):922-3. PubMed ID: 24896761
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Abdallah et al.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2014 Apr; 109(4):602-3. PubMed ID: 24698871
    [No Abstract]   [Full Text] [Related]  

  • 14. How much do PPIs contribute to C. difficile infections?
    Leontiadis GI; Miller MA; Howden CW
    Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
    Roughead EE; Chan EW; Choi NK; Griffiths J; Jin XM; Lee J; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Nguyen TA; Ooba N; Park BJ; Sato T; Shin JY; Wang T; Wong IC; Yang YK; Pratt NL
    Expert Opin Drug Saf; 2016 Dec; 15(12):1589-1595. PubMed ID: 27645304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.